The 23rd edition of BioAsia 2026 — Asia's largest life sciences summit — was inaugurated on February 17, 2026 by Telangana Chief Minister A. Revanth Reddy at HITEX Exhibition Centre, Hyderabad, under the theme 'TechBio Unleashed: AI, Automation & the Biology Revolution'. The two-day event (February 17–18) attracted over 4,000 delegates from 50 countries and participation from more than 500 companies — the largest in BioAsia's history.

Key announcements: CM Revanth Reddy connected the summit to the Telangana Rising 2047 vision, which aims to make Telangana a $1 trillion economy by 2034 and a $3 trillion economy by 2047, and linked it to Hyderabad's transition from vaccine capital to biotechnology capital. Keynote sessions featured global experts including Prof. Bruce Levine (University of Pennsylvania), Dr. Howard Y. Chang (Amgen), and Pushmeet Kohli (Google DeepMind), with a focus on AI-driven drug discovery, biomanufacturing, and advanced therapeutic modalities.

Major global companies such as Novartis, Eli Lilly, Thermo Fisher Scientific, Sanofi, and MSD, along with Indian leaders Dr. Reddy's Laboratories and Biocon Biologics, participated prominently. The summit underscores India's emergence as a global TechBio hub, combining strengths in pharmaceutical manufacturing, AI capabilities, and biotech research. Hyderabad — considered the Life Sciences Capital of India with over 800 life sciences companies — remains the centrepiece of India's biotech ambition, anchored by its Genome Valley cluster.